US continues to be a top destination for pharma jobs in recent months
Apellis eye injection treatment flagged for safety issues
Drugmakers go under the skin, skirting early US Medicare price negotiations
Big Pharma CEOs get candid about pricing and M&A
*please scroll down for all the latest news*
